A Phase 3 Study to Evaluate the Efficacy and Safety of Resiniferatoxin for Pain Due to Osteoarthritis of the Knee

NCT04044742 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped To be replaced by a different protocol

Conditions

Osteoarthritis, Knee
Knee Pain Chronic

Interventions

DRUG: Resiniferatoxin
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.